← Back to Search

Behavioral Intervention

Savvy Caregiver Training for Dementia

N/A
Waitlist Available
Led By Kenneth Hepburn, MD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 12 months
Awards & highlights

Study Summary

This trial will develop a system to train caregivers of people with dementia, to help increase how many people the program can reach.

Who is the study for?
This trial is for adults who speak English and are involved with organizations serving dementia caregivers. It includes organizational leaders, interventionists, and caregivers providing at least 3 hours of daily informal care to someone with Alzheimer's or related dementias not expected to need institutional care soon.Check my eligibility
What is being tested?
The study is testing a web-based system designed to train people in delivering the Savvy Caregiver program—a psychoeducation program for dementia family caregivers—using online methods, manuals, and protocols.See study design
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, traditional physical side effects are not applicable. Participants may experience emotional or psychological responses due to the nature of caregiver education.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Center for Epidemiologic Studies - Depression Scale (CES-D) score
Secondary outcome measures
Change in Anxiety score
Change in Caregiver Assessment of Behavioral Skill score
Change in Caregiver Pearlin Mastery score
+2 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Savvy ParticipantsExperimental Treatment1 Intervention
Using an on-line survey method, each caregiver will be asked to complete the post-program fidelity monitoring survey that seeks responses to the program (feel more knowledgeable, more competent, better equipped, etc.) and asks them to assess the interventionist's performance and verify that certain key elements of the program were covered.
Group II: Organizational LeadersExperimental Treatment1 Intervention
Recorded semi-structured video interviews with sponsoring organizations' key contact persons will be conducted immediately after the interventionist training and then after each of two Savvy offerings. The conversation will focus on identifying ways to strengthen and improve the training, certification, and fidelity monitoring system. Information about time and resource costs of the program, caregiver demand, and caregiver recruitment and feedback (3 interviews per organization) will be also collected.
Group III: InterventionistsExperimental Treatment1 Intervention
Three recorded semi-structured video interviews will be conducted with each interventionist. One will occur immediately after training; this will focus on their sense of the completeness and adequacy of the training program, including the training methods, videos, and materials, and their perceived readiness to lead the program. Another interview will be done immediately after the conduct of each of the two Savvy programs they lead, asking them to report on their own performance as interventionists, including any adaptation processes in which they might have engaged, and to reflect on ways the training might be improved to strengthen their skills, including for adaptation. In total: 18 interviews.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Savvy program
2021
N/A
~120
Semi-structured video interviews
2021
N/A
~120

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,669 Previous Clinical Trials
28,004,994 Total Patients Enrolled
265 Trials studying Dementia
23,623,291 Patients Enrolled for Dementia
Emory UniversityLead Sponsor
1,636 Previous Clinical Trials
2,560,453 Total Patients Enrolled
20 Trials studying Dementia
2,716 Patients Enrolled for Dementia
Kenneth Hepburn, MDPrincipal InvestigatorEmory University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are being recruited for participation in this clinical trial?

"Indeed, clinicaltrials.gov displays that this study is currently recruiting for participants. The trial was initially posted on August 4th 2021 and has most recently been updated on November 1st 2022. A total of 174 individuals are needed to be recruited from a single medical site."

Answered by AI

Are there any openings for participants in this experiment?

"This trial is actively attempting to enroll participants, as evidenced by the information found on clinicaltrials.gov. This research project was inaugurated in August 2021 and revised most recently in November 2022."

Answered by AI
~33 spots leftby Apr 2025